Literature DB >> 28154259

Xiao Yao San Improves the Anxiety-Like Behaviors of Rats Induced by Chronic Immobilization Stress: The Involvement of the JNK Signaling Pathway in the Hippocampus.

Hong-Bo Zhao1, You-Ming Jiang, Xiao-Juan Li, Yue-Yun Liu, Xiao-Hui Bai, Na Li, Jia-Xu Chen, Qun Liu, Zhi-Yi Yan, Fang-Zhou Zhao.   

Abstract

The current study evaluated the effects of Xiao Yao San (XYS) on anxiety-like behaviors and sought to determine whether the c-Jun N-terminal kinase (JNK) signaling pathway is involved. A total of 40 rats were divided into 5 groups (n=8): the control group (deionized water, per os (p.o.)), the model group (deionized water, p.o.), the SP600125 group (surgery), the per se group (surgery), and the XYS group (3.9 g/kg/d, p.o.). A 1% dimethyl sulfoxide (DMSO) citrate buffer solution (2 µL/ventricle/d) and SP600125 (10 µg/ventricle, 2 µL/ventricle/d) were separately and bilaterally injected into the rats of the two surgery groups via the ventricular system of the brain. All but the control group underwent 14 d of chronic immobilization stress (CIS; 3 h/d). On day 15, the body weights of all of the rats were measured; additionally, the rats were subjected to the elevated plus maze (EPM) and novelty suppressed feeding (NSF) tests. Finally, JNK signaling pathway indices, including phosphorylated JNK (P-JNK), JNK, phosphorylated c-Jun (P-c-Jun) and cytochrome C (Cyt-C), were examined. After modeling, the body weight and behavioral analyses of the model rats indicated that this modeling method induced anxiety-like behaviors. P-JNK, JNK, and P-c-Jun were altered in the hippocampus of the model rats. After 14 d of treatment with XYS and SP600125, rat body weight and behaviors as well as P-JNK, JNK, and P-c-Jun had changed. However, no significant difference in Cyt-C was found. XYS improves the anxiety-like behaviors induced by CIS, which might be related to the JNK signaling pathway in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28154259     DOI: 10.1248/bpb.b16-00694

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Xiaoyaosan prevents atherosclerotic vulnerable plaque formation through heat shock protein/glucocorticoid receptor axis-mediated mechanism.

Authors:  Wenjun Fu; Mingtai Chen; Lijun Ou; Tao Li; Xiao Chang; Ruolan Huang; Jian Zhang; Zhong Zhang
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  Influence of Xiaoyaosan on depressive-like behaviors in chronic stress-depressed rats through regulating tryptophan metabolism in hippocampus.

Authors:  Haiyan Jiao; Zhiyi Yan; Qingyu Ma; Xiaojuan Li; Youming Jiang; Yueyun Liu; Jiaxu Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2018-12-18       Impact factor: 2.570

3.  Xiaoyaosan Improves Antibiotic-Induced Depressive-Like and Anxiety-Like Behavior in Mice Through Modulating the Gut Microbiota and Regulating the NLRP3 Inflammasome in the Colon.

Authors:  Wenzhi Hao; Jiajia Wu; Naijun Yuan; Lian Gong; Junqing Huang; Qingyu Ma; Huizheng Zhu; Hua Gan; Xiaoli Da; Lijuan Deng; Xiaojuan Li; Jiaxu Chen
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

4.  Xiaoyaosan (Tiaogan-Liqi therapy) protects peritoneal macrophages from corticosterone-induced stress by regulating the interaction between glucocorticoid receptor and ABCA1.

Authors:  Mingtai Chen; Ruolan Huang; Wenjun Fu; Lijun Ou; Ling Men; Zhong Zhang; Shudong Yang; Qiang Liu; Jienan Luan
Journal:  Ann Transl Med       Date:  2020-11

5.  Danzhi Xiaoyao Powder Promotes Neuronal Regeneration by Downregulating Notch Signaling Pathway in the Treatment of Generalized Anxiety Disorder.

Authors:  Chao Liu; Zhenhao Ying; Zifa Li; Long Zhang; Xin Li; Wenbo Gong; Jiang Sun; Xuejing Fan; Ke Yang; Xingchen Wang; Sheng Wei; Ning Dong
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

Review 6.  Research progress on classical traditional chinese medicine formula xiaoyaosan in the treatment of depression.

Authors:  Jianbei Chen; Chaofang Lei; Xiaojuan Li; Qian Wu; Chenyue Liu; Qingyu Ma; Jiaxu Chen
Journal:  Front Pharmacol       Date:  2022-08-04       Impact factor: 5.988

7.  Xiaoyaosan Improves Depressive-Like Behaviors in Mice through Regulating Apelin-APJ System in Hypothalamus.

Authors:  Zhiyi Yan; Haiyan Jiao; Xiufang Ding; Qingyu Ma; Xiaojuan Li; Qiuxia Pan; Tingye Wang; Yajing Hou; Youming Jiang; Yueyun Liu; Jiaxu Chen
Journal:  Molecules       Date:  2018-05-03       Impact factor: 4.411

8.  Xiaoyao Pills Prevent Lipopolysaccharide-Induced Depression by Inhibiting Inflammation and Protecting Nerves.

Authors:  Boyu Shi; Jie Luo; Yang Fang; Xiaobo Liu; Zhili Rao; Rong Liu; Nan Zeng
Journal:  Front Pharmacol       Date:  2019-11-13       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.